Similar to those findings, our data suggest that p300, present at relatively high levels in CLL cells, induces acetylation of STAT3 and that acetylated STAT3 provides CLL cells with survival advantage. The gene discussed is EP300; the disease is B-cell chronic lymphocytic leukemia.